Fulcrum Therapeutics (FULC) EPS (Basic) (2018 - 2026)
Fulcrum Therapeutics (FULC) posted quarterly EPS (Basic) of -$0.46 for Q2 2026, down 65.88% year-over-year from -$1.34 in Q2 2025, and up 30.03% quarter-over-quarter from -$0.66 in Q1 2026.
Fulcrum Therapeutics (FULC) EPS (Basic) (2018 - 2026) Analysis & Trends
Fulcrum Therapeutics (FULC) has reported EPS (Basic) for 9 consecutive years, with -$0.46 the latest figure, recorded in Q2 2026.
- In Q2 2026, EPS (Basic) fell 65.88% year-over-year to -$0.46; the TTM figure through Jun 2026 stood at -$2.47 (down 65.6% YoY), while the FY2025 annual figure was -$2544.9, down 114.95% from the prior year.
- EPS (Basic) improved to -$0.46 in Q2 2026 per FULC's latest filing, from -$0.66 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.89 in Q2 2024 and bottomed at -$1328.3 in Q4 2025.
- Historically, EPS (Basic) has averaged -$428.53 across 5 years, with a median of -$386.68 in 2023.
- Annual changes were most pronounced in 2023 — EPS (Basic) plunged 30210.29% — and 2024, when it jumped 100.23%.
- Fulcrum Therapeutics' EPS (Basic) stood at -$663.65 in 2022, then declined by 5.94% to -$703.08 in 2023, then jumped by 42.56% to -$403.84 in 2024, then tumbled by 228.91% to -$1328.3 in 2025, then surged by 99.97% to -$0.46 in 2026.
- Business Quant data shows FULC's EPS (Basic) at -$0.46 in Q2 2026, -$0.66 in Q1 2026, and -$1328.3 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Fulcrum Therapeutics | 285.31 Mn | 285.31 Mn | - | -0.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.46 |
| Mar 31, 2026 | -0.66 |
| Dec 31, 2025 | -1,328.26 |
| Sep 30, 2025 | -0.31 |
| Jun 30, 2025 | -0.28 |
| Mar 31, 2025 | -0.47 |
| Dec 31, 2024 | -403.84 |
| Sep 30, 2024 | -0.35 |
| Jun 30, 2024 | 0.89 |
| Mar 31, 2024 | -1,052.51 |
| Dec 31, 2023 | -703.08 |
| Sep 30, 2023 | -388.48 |
| Jun 30, 2023 | -384.88 |
| Mar 31, 2023 | -511.08 |
| Dec 31, 2022 | -4,277.66 |
| Sep 30, 2022 | -586.07 |
| Jun 30, 2022 | -866.76 |
| Mar 31, 2022 | -2.31 |
| Dec 31, 2021 | -1,440.88 |
| Sep 30, 2021 | -2,635.30 |